Exploring the utility of serum anti-tNASP antibodies as a screening biomarker in prostate, pancreatic, and ovarian cancer
Document Type
Article
Date of Publication
10-2023
Publication Title
Annals of Oncology
First Page
243
DOI
https://doi.org/10.1016/j.annonc.2023.09.2879
Recommended Citation
Alekseev, O. M.; Yi, X.; Kasmenn, M.; Kundu, S.; Rogers, M.; and Vaskalis, Z., "Exploring the utility of serum anti-tNASP antibodies as a screening biomarker in prostate, pancreatic, and ovarian cancer" (2023). Osteopathic Medicine, Jerry M. Wallace School of. 2195.
https://cufind.campbell.edu/medicine_school/2195
COinS
